Effect of Pharmacogenetic-Based Dosing of Warfarin on Bleeding During Anticoagulation in Russian Patients: A Systematic Review and Meta-Analysis

Effect of Pharmacogenetic-Based Dosing of Warfarin on Bleeding During Anticoagulation in Russian Patients: A Systematic Review and Meta-Analysis

To summarize the current evidence supporting the use of genetic testing before prescribing warfarin, we performed a meta-analysis of Russian prospective studies that compared a dose-selection strategy that used pharmacogenetic information versus one that did not.

Saved in:
Bibliographic Details
Published in:Clinical therapeutics Vol. 36; no. 8; p. e1
Main Authors: Ivashchenko, D.V, Rusin, I.V, Sychev, D.A
Format: Journal Article
Language:English
Published: Bridgewater Elsevier Limited 01-08-2014
Subjects:
Genetic testing
Internal Medicine
Medical Education
Meta-analysis
Studies
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To summarize the current evidence supporting the use of genetic testing before prescribing warfarin, we performed a meta-analysis of Russian prospective studies that compared a dose-selection strategy that used pharmacogenetic information versus one that did not.
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2014.05.013